Astellas Pharma Global Development, Inc.

This study tested a new drug called ASKP1240 in 149 people who received a new kidney. The goal was to see if it could help prevent the body from rejecting the new kidney. Researchers compared different combinations of medicines to find a safer and more effective way to protect th…

This study tested an experimental drug called Zimura (avacincaptad pegol) in 121 people with Stargardt disease, an inherited eye condition that causes vision loss. The drug was given as an injection into the eye and compared to a sham procedure. The goal was to see if Zimura coul…

This study tested a new drug called gilteritinib against standard chemotherapy in 371 people with a specific genetic form of acute myeloid leukemia (FLT3-mutated AML) that had returned or not improved after initial treatment. The goal was to see if gilteritinib helped people live…

This study tested whether adding enzalutamide to standard hormone therapy (ADT) helps men with prostate cancer that has spread to other parts of the body. About 1,150 men took part. The goal was to see if the combination delayed cancer growth on scans and improved survival. Resul…

This study tested a new drug combination for adults newly diagnosed with acute myeloid leukemia (AML) that has a specific gene change (FLT3 mutation). Participants were not healthy enough for standard strong chemotherapy. The study compared the current standard drug (azacitidine)…

This study checks the long-term safety of an eye injection called avacincaptad pegol for people with geographic atrophy, a form of advanced age-related macular degeneration. It includes 278 adults aged 50 and older who completed a previous study of the same drug. The main goal is…

This study tested a new drug called enfortumab vedotin against standard chemotherapy in 608 adults with advanced bladder or urinary tract cancer that had worsened after prior treatment. The goal was to see if the new drug helped people live longer and slowed cancer growth. Result…

This study tested a new dye called ASP5354 that makes the ureter glow under a special camera during abdominal surgery. The goal was to see if this dye helps surgeons spot the ureter more clearly than standard white light, potentially preventing accidental injury. About 95 adults …

This study tested a new dye called ASP5354 that makes the ureter glow under a special camera during abdominal surgery. The goal was to help surgeons avoid accidentally injuring the ureter. Over 100 people aged 12 and older took part. The dye was injected at the start of surgery, …

This study tested an experimental drug called ASKP1240 in 60 adults with moderate to severe plaque psoriasis. The main goal was to check the drug's safety and how the body processes it, while also looking for early signs that it might improve skin symptoms. Participants received …

This study tested a new drug called ASP8062 to see if it could reduce pain in people with fibromyalgia. 183 adults took either the drug or a placebo for 8 weeks. Researchers measured pain levels using a 0-10 scale and watched for side effects.

This study tested a daily pill called fezolinetant to see if it safely reduces hot flashes and night sweats in Chinese women going through menopause. About 150 women took either the drug or a placebo for 12 weeks. The goal was to measure how much their hot flash frequency and sev…